25 July 2019

Reig Jofre closes the first half of 2019 with a sales growth of 3% and EBITDA of 6%

22 July 2019

Reig Jofre starts the first tranche of the second share buyback program

1 July 2019

Reig Jofre acquires Bioibérica’s portfolio of finished pharmaceutical and nutraceutical products, representing a turnover of € 26M

21 June 2019

Start date of trading for the new shares resulting from the capital increase

17 June 2019

Reig Jofre increases its capital amounting to euros 24 million to finance its expansion plan

17 June 2019

Reig Jofre informs on the result of the increase of the share capital

13 June 2019

Report on the increase of the Company’s share capital

12 June 2019

Start date of the trading of the new shares within its scrip dividend

31 May 2019

Bonus-shares capital increase and new shares to be issued

9 May 2019

Reig Jofre closes the first quarter of 2019 with a sales growth of 6% and net profit of 8%

6 May 2019

Execution of the scrip dividend

30 April 2019

Conditions of the scrip dividend

25 April 2019

Resolutions on 2019 shareholders’ meeting

27 March 2019

Reig Jofre awarded with the Best Business Initiative

25 March 2019

Reig Jofre convenes its 2019 General Shareholders´ Meeting

20 March 2019

Reig Jofre starts marketing its products in South Korea

28 February 2019

Results preview: Year 2018

23 January 2019

Publication schedule for 2019 results

11 January 2019

Ceremony to lay the First Stone of the plant expansion of sterile injectable medicines of Reig Jofre

3 December 2018

Transactions within the share buyback program